Altretamine (drug discontinued 2019)
Experienced Physician; Peripheral Blood Counts; Neurological Examinations
- Altretamine should only be given under the supervision of a physician experienced in the use of antineoplastic agents.
Peripheral Blood Counts
- Peripheral blood counts should be monitored at least monthly, prior to the initiation of each course of altretamine, and as clinically indicated.
- Because of the possibility of altretamine capsules-related neurotoxicity, neurologic examination should be performed regularly during therapy.
Patient Counseling Information
Updated January 2023